盘龙药业：公司在中药创新药方面秉持“把握前沿、仿创结合”的原则

Core Viewpoint - The company, Panlong Pharmaceutical, emphasizes its commitment to innovation in traditional Chinese medicine, focusing on a combination of original research and imitation of effective foreign drugs nearing patent expiration [1] Group 1: Research Directions - The company is pursuing four major research directions: 1. Conducting mechanism studies, process optimization, quality standard upgrades, and developing new formulations and indications for proprietary traditional Chinese medicine products [1] 2. Imitating foreign chemical drugs that have proven efficacy, strong market competitiveness, and are approaching patent expiration [1] 3. Developing new traditional Chinese medicines based on the "three-combination" evidence system, particularly targeting unique products in the fields of rheumatism, bone diseases, and chronic pain [1] 4. Aligning with new trends in the pharmaceutical industry by investing in targeted small molecule drugs and biopharmaceuticals [1]